Insider Transactions in Q3 2025 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
806
-0.37%
|
$11,284
$14.64 P/Share
|
|
Aug 12
2025
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,937
-1.33%
|
$38,181
$13.58 P/Share
|
|
Aug 12
2025
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,937
-1.2%
|
$38,181
$13.58 P/Share
|
|
Aug 05
2025
|
Carole Ho Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,655
+16.85%
|
$0
$0.68 P/Share
|
|
Jul 09
2025
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
495,282
-66.18%
|
$7,429,230
$15.0 P/Share
|
|
Jul 09
2025
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
495,282
+22.1%
|
$990,564
$2.98 P/Share
|